- Last updated
IACM-Bulletin of December 26, 2004
🌐 Canada — GW Pharmaceuticals will get approval for Sativex by Canadian regulators
The cannabis extract Sativex of the British firm GW Pharmaceuticals received Qualifying Notice for approval by the Canadian health ministry (Health Canada). Sativex will initially be indicated in Canada for the relief of neuropathic pain in multiple sclerosis.